Publicaciones en colaboración con investigadores/as de Universitat Internacional de Catalunya (47)

2024

  1. Ethical challenges during critical phases of the COVID-19 pandemic: An interpretive synthesis

    Nursing Ethics

  2. Nomenclature in palliative care and renal support: Not just at the end-of-life

    Nefrologia, Vol. 44, Núm. 4, pp. 475-485

  3. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

  4. Social media and mental health: The role of interpersonal relationships and social media use motivations, in a nationally representative, longitudinal sample of Spanish emerging adults

    Journal of Social and Personal Relationships, Vol. 41, Núm. 5, pp. 1157-1182

2023

  1. Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  2. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

2021

  1. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  2. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

  3. Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    Intensive Care Medicine

  4. Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo

    Molecular Systems Biology, Vol. 17, Núm. 10

  5. Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 1, pp. 29-40

  6. Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 11-26

  7. Hypersensitivity reactions to cancer chemotherapy: Practical recommendations of aradyal for diagnosis and desensitization

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 5, pp. 364-384

  8. Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Adverse Drug Reactions and Allergy Network) Spanish allergy services

    Allergy: European Journal of Allergy and Clinical Immunology

  9. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  10. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

  2. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

  3. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837